Zobrazeno 1 - 10
of 72
pro vyhledávání: '"ovarian cancer recurrence"'
Secondary cytoreduction in recurrent ovarian cancer- experience from a tertiary care centre in India
Autor:
Priya Bhati, Anitha Thomas, Rachel George Chandy, Amrita Datta, Dhanya Susan Thomas, Vinotha Thomas, Abraham Peedicayil, Ajit Sebastian
Publikováno v:
Gynecologic Oncology Reports, Vol 54, Iss , Pp 101463- (2024)
Introduction: Ovarian cancer is a disease that presents in advanced stage, due to the absence of any specific or overtly dramatic symptoms. The standard of care is primary debulking surgery, followed by chemotherapy. Ovarian cancer recurrence treatme
Externí odkaz:
https://doaj.org/article/606ee6fb247a4fb094f745087a3b9eb2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Libri Oncologici, Vol 50, Iss 1, Pp 16-26 (2022)
Aim: To evaluate the treatment outcomes, with emphasis on the efficacy and safety of olaparib, in patients with platinum-sensitive, BRCA-mutated, recurrent ovarian cancer treated at the University Hospital Center Split in the period from June 2016 to
Externí odkaz:
https://doaj.org/article/ab0a578de21d4eadb3470375f60e8b62
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Ovarian cancer represents worldwide the second most frequent and the most fatal gynecological malignancy, with approximately two thirds of the patients presenting with advanced disease. Cytoreductive surgery, primary or after neoadjuvant chemotherapy
Externí odkaz:
https://doaj.org/article/57aa9ed5c7ec40e68e3124c964f31d77
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Acta Medica Leopoliensia, Vol 23, Iss 3, Pp 31-38 (2017)
Aim. Safety, efficiency and diagnostic value of diagnostic and curative thoracic surgical interventions were the objectives of current research dedicated to patients with recurrent ovarian cancer. Materials and Methods. Retrospective analysis of m
Externí odkaz:
https://doaj.org/article/8edf138aba70428fa838fdb298765a89
Autor:
Giuseppe Vocaturo, Giuseppe Cutillo, Enrico Vizza, Ermelinda Baiocco, Valentina Bruno, Benito Chiofalo, Cristina Vincenzoni, Emanuela Mancini, Simone Bruni, Rosanna Mancari
Publikováno v:
Gland Surg
Epithelial ovarian cancer (EOC) is the scariest gynaecological cancer. Many advances have been done with evolving knowledge, leading to the introduction of new drugs, most in maintenance setting. The antiangiogenic Bevacizumab and the three approved
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a79ae93e010693221961e2213b348e6f
https://doi.org/10.21037/gs-20-413
https://doi.org/10.21037/gs-20-413
Autor:
Stefano Uccella, Carmine Vascone, Camilla Fedele, Mariateresa Mirandola, Virginia Vargiu, Andrea Rosati, Salvatore Gueli Alletti, Vito Andrea Capozzi
Publikováno v:
Gland Surg
Nowadays, no standard approaches for follow up in ovarian cancer (OC) patients exist. While the role of ultrasound (US) is well defined in primary diagnosis of OC, it is still controversial during follow-up of surgically treated OC. The aim of this n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e0ae1692289a1215ea055d75ea07c79
https://doi.org/10.21037/gs-20-357
https://doi.org/10.21037/gs-20-357
Publikováno v:
Libri Oncologici : Croatian Journal of Oncology
Volume 50
Issue 1
Volume 50
Issue 1
Aim: To evaluate the treatment outcomes, with emphasis on the efficacy and safety of olaparib, in patients with platinum-sensitive, BRCA-mutated, recurrent ovarian cancer treated at the University Hospital Center Split in the period from June 2016 to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______951::e3c6206b3222e72fc2ae1099f86665fa
https://hrcak.srce.hr/277743
https://hrcak.srce.hr/277743